-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – HM-01 in Chemotherapy Induced Peripheral Neuropathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. HM-01 in Chemotherapy Induced Peripheral Neuropathy Drug Details: HM-01 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SYD-4228 in Follicular Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. SYD-4228 in Follicular Lymphoma Drug Details: SYD-4228 is under development for the treatment of metastatic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – VAX-24 in Streptococcal Pneumonia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.VAX-24 in Streptococcal Pneumonia Drug Details:VAX-24 is under development for the prevention of Streptococcus pneumonia infections...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dihydroergotamine Mesylate (Dhe) in Migraine
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Dihydroergotamine Mesylate (Dhe) in MigraineDrug Details:Dihydroergotamine mesylate is under development for the treatment of migraine and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Efzofitimod in Pulmonary Sarcoidosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Efzofitimod in Pulmonary Sarcoidosis Drug Details: efzofitimod (ATYR-1923) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Anamorelin Hydrochloride in Chemotherapy Effects
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Anamorelin Hydrochloride in Chemotherapy Effects Drug Details: Anamorelin hydrochloride (Adlumiz) is a synthetic, small-molecule ghrelin mimetic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Anamorelin Hydrochloride in Fatigue
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Anamorelin Hydrochloride in FatigueDrug Details: Anamorelin hydrochloride (Adlumiz) is a synthetic, small-molecule ghrelin mimetic with appetite-stimulating...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Anamorelin Hydrochloride in Cancer Anorexia-Cachexia Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Anamorelin Hydrochloride in Cancer Anorexia-Cachexia SyndromeDrug Details: Anamorelin hydrochloride (Adlumiz) is a synthetic, small-molecule ghrelin mimetic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Head And Neck Cancer Squamous Cell Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Head And Neck Cancer Squamous Cell Carcinoma Drug Details: PD-L1/IDO (IO102/IO103)...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Neratinib in Cervical Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Neratinib in Cervical Cancer Drug Details: Neratinib (Nerlynx) is a member of the 4-anilino quinolidine...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.